AlbertT.QuieryJr.MDMSc FACP
Hematology • Asheville, NCBlood Banking & Transfusion Medicine, Clotting Disorder, Hematologic Oncology
Medical Director
Dr. Quiery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
21 Hospital Dr
4th Floor
Asheville, NC 28801Phone+1 828-253-4262- Is this information wrong?
Education & Training
Creighton University, School of MedicineMaster of Science, Health Care Ethics, 2011 - 2014
Stony Brook MedicineFellowship, Blood Banking/Transfusion Medicine, 1990 - 1992
Duke University HospitalFellowship, Hematology and Medical Oncology, 1988 - 1989- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1984 - 1988
Albert Einstein College of MedicineClass of 1984- Stony Brook UniversityB.S, Biochemistry, Phi Beta Kappa, 1976 - 1980
Certifications & Licensure
TN State Medical License 2023 - 2026
NC State Medical License 2019 - 2025
MI State Medical License 2014 - 2021
PA State Medical License 1991 - 2014
NY State Medical License 1985 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Pathology Blood Banking/Transfusion Medicine
Awards, Honors, & Recognition
- Alpha Omega Alpha Stony Brook University School of Medicine, 1987
- Phi Beta Kappa SUNY Stony Brook, 1980
- Fellow (FACP) American College of Physicians, 2005
Publications & Presentations
PubMed
- 58 citationsSafety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.DeAngelo, D., Radia, D., George, T., Robinson, W., Quiery, A., Drummond, M., Bose, P., Hexner, E., Winton, E., Horny, H., Tugnait, M., Schmidt-Kittler, O., Evans, E., ...> ;Nature Medicine. 2021 Dec 1
- 174 citationsRuxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.Asra Ahmed, Samuel A. Merrill, Fares Alsawah, Paula L. Bockenstedt, Erica L. Campagnaro, Sumana Devata, Scott D. Gitlin, Mark S. Kaminski, Alice M. Cusick, Tycel Phill...> ;The Lancet. Haematology. 2019 Sep 16
- 70 citationsNCCN guidelines® insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelinesArnel Pallera, Jessica K. Altman, Ellin Berman, Camille N. Abboud, Bhavana Bhatnagar, Peter T. Curtin, Daniel J. DeAngelo, Jason Gotlib, R. Tanner Hagelstrom, Gabriela...> ;Journal of the National Comprehensive Cancer Network. 2016 Dec 1
- Join now to see all
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
